Search

Your search keyword '"Gabrielle, Pierre-Henry"' showing total 370 results

Search Constraints

Start Over You searched for: Author "Gabrielle, Pierre-Henry" Remove constraint Author: "Gabrielle, Pierre-Henry"
Sorry, I don't understand your search. ×
370 results on '"Gabrielle, Pierre-Henry"'

Search Results

Catalog

Books, media, physical & digital resources

11. Update on Retinal Vein Occlusion

14. Polypoidal Choroidal Vasculopathy Based on Non-ICGA Criteria in White Patients With Neovascular Age-Related Macular Degeneration

18. Two-year outcomes of Xen 45 gel stent implantation in patients with open-angle glaucoma: real-world data from the Fight Glaucoma Blindness registry.

20. One-year anti-VEGF therapy outcomes in diabetic macular edema based on treatment intensity: Data from the FRB! registry

21. Presumed Natural History of Combined Hamartoma of the Retina and Retinal Pigment Epithelium

22. Mucosal-associated invariant T cells in Giant Cell Arteritis

23. Three-Year Outcomes of VEGF Inhibitors in Naive Branch Retinal Vein Occlusion

24. Subclinical subretinal fluid detectable only by optical coherence tomography in choroidal naevi—the SON study

27. Long-term intake of Lactobacillus helveticus enhances bioavailability of omega-3 fatty acids in the mouse retina

28. European Unmet Needs in the Management of Neovascular Age-Related Macular Degeneration in Daily Practice

30. Cystoid maculopathy is a frequent feature of Cohen syndrome-associated retinopathy

31. Peripapillary Versus Macular Combined Hamartoma of the Retina and Retinal Pigment Epithelium: Imaging Characteristics

33. Real-world outcomes of observation and treatment in diabetic macular edema with very good visual acuity: the OBTAIN study

35. A Retinal Oct-Angiography and Cardiovascular STAtus (RASTA) Dataset of Swept-Source Microvascular Imaging for Cardiovascular Risk Assessment

36. 12-month outcomes of treatment-naïve retinal vein occlusion initially treated with either dexamethasone implants or vascular endothelial growth factor inhibitors: Data from the Fight Retinal Blindness! registry

37. Cholesterol metabolism and glaucoma: Modulation of Muller cell membrane organization by 24S-hydroxycholesterol

40. Shall we stay, or shall we switch? Continued anti-VEGF therapy versus early switch to dexamethasone implant in refractory diabetic macular edema

42. Early Retinal Microvascular Changes Assessed with Swept-Source OCT Angiography in Type 1 Diabetes Patients without Retinopathy

43. STAR: a randomized controlled trial for submacular hemorrhage secondary to age-related macular degeneration

44. Association of lipid-lowering drugs and antidiabetic drugs with age-related macular degeneration:A meta-analysis in Europeans

45. Does HbA1c Level or Glomerular Filtration Rate Affect the Clinical Response to Endothelial Growth Factor Therapy (Ranibizumab or Aflibercept) in Diabetic Macular Edema? A Real-Life Experience

46. Changes in 12-month outcomes over time for age-related macular degeneration, diabetic macular oedema and retinal vein occlusion

47. Hemiretinal vein occlusion 12-month outcomes are unique with vascular endothelial growth factor inhibitors: data from the Fight Retinal Blindness! Registry

48. Central retinal vein occlusion 36-month outcomes with anti-vascular endothelial growth factors: the Fight Retinal Blindness! registry

49. Incidence, risk factors and outcomes of submacular haemorrhage with loss of vision in neovascular age-related macular degeneration in daily clinical practice: data from the FRB! registry

50. Incidence, Risk Factors, and Outcomes of Rhegmatogenous Retinal Detachment after Intravitreal Injections of Anti-VEGF for Retinal Diseases: Data from the Fight Retinal Blindness! Registry